AcquisitionOther
Inhibitor Therapeutics, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Inhibitor Therapeutics, Inc. -> target · $3,000,000 b
After the Effective Date, Mayne Pharma has also agreed it will remain amenable to discussing with the Company, in good faith, the potential licensing and/or sub- licensing of the JHU Patents (as defined in the Settlement Agreement), for a commercially reasonab
Open source record (SEC) ↗